Minerva neurosciences inc

Major-Pharmaceuticals

NERV


1601 Trapelo Road
Waltham , MA 02451

Executive/
Director

Price

  • Last Close
  • $ 2.34
    $ -0.05 -2.09 %
    Dec 10, 2024
  • 52-Week High/Low
  • $12.47 - $2.37
  • YTD
  • -62%

  • Trading Volume
  • 111
  • Market Cap Full
  • $ 16.4M
  • Shares Outstanding
  • 7M
    Nov 2, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -16.9% 1.2% -31.1% 3.3% 16.6% -5% 24.8% 2% 0.6% -58.1%
Q2 16% 66.3% 9.3% 33.1% -28.2% 4% -20.6% 306.1% 471.3% -1.8%
Q3 -9.5% 38.3% -14.1% 51.2% 39.6% 8% -25% 178.9% -24.5% -
Q4 15.6% -16.8% -23.4% -43.4% -6.9% -26.4% -54.1% -82.8% -8.1% -
J F M A M J J A S O N D
2024 37.4% -68.4% -3.4% -2.5% - - - - - - - -
2023 50.3% -9.6% -25.9% 73.1% 115.5% 53.1% 4.1% -12% -17.6% -30.1% 62.9% -21.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%1%94%-49%11%6%-67%-66%99%287%-62%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.31 0.29 0.30 -0.32 -0.41 -0.31 -0.21 -1.84 -1.31
Q2 0.27 0.18 0.27 -0.32 -0.32 0.73 -0.25 -1.63 -1.12
Q3 0.24 0.24 0.28 -0.31 -0.36 -0.19 -0.22 -1.29 -1.03
Q4 0.34 0.27 0.24 -0.34 -0.76 -0.18 -3.97 -1.25 -
A 1.2 1 1.1 -1.3 -1.9 0.1 -9.4 -6 -3.46

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 39 39.2 42.7 42.7 5.3
Jun 38.7 39 39.2 42.7 42.7 5.6
Sep 38.8 39 41.2 42.7 5.3 7
Dec 38.9 39 42.7 42.7 5.3 7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - 2.7 - -
Total Asset Turnover - - 0.7 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -3.6 -9 - 19 26
Equity multiplier - - 0.3 0.5 0.4